Sanalitro supports HB4203 to broaden cancer screening coverage; bill passes Illinois House unanimously

Rep. Jennifer Sanalitro (R-48th) cast a Yes vote on HB4203, legislation aimed at expanding insurance coverage for cancer screenings, during the 104th General Assembly on May 31, 2026, according to the Illinois House. The bill passed with a 115-0 vote.

The official bill summary describes the proposal as: "INS CD-CANCER SCREENINGS."

The following summary is based on the original bill text and may offer interpretations to clarify key elements.

In summary, the bill updates the Illinois Insurance Code to extend coverage for specific cancer screenings. The legislation includes individuals with elevated CA-125 levels as being "at risk for ovarian cancer." It requires insurers to cover annual cervical smear or Pap tests, annual prostate cancer screenings for defined groups, and ovarian cancer monitoring with varied approved methods such as ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood work — all without cost-sharing. Certain limited coverage and high-deductible health savings account-eligible plans are excluded. The effective date is Jan. 1, 2028.

The legislative action recorded for HB4203 was "Senate Floor Amendment No. 1 House Concurs."

Sanalitro, a Republican, began representing Illinois’ 48th House District in 2023, succeeding former state representative Terra Costa Howard.

Illinois legislation follows a multi-step legislative process involving introduction in one of the chambers, committee discussions, floor debate, passage in both the House and Senate, and forwarding to the governor for approval or veto. The General Assembly's biennial cycle sees thousands of bills introduced each session, with only a small percentage becoming law.